Proteomic technology for biomarker profiling in cancer: an update


The progress in the understanding of cancer progression and early detection has been slow and frustrating due to the complex multifactorial nature and heterogeneity of the cancer syndrome. To date, no effective treatment is available for advanced cancers, which remain a major cause of morbidity and mortality. Clearly, there is urgent need to unravel novel… (More)
DOI: 10.1631/jzus.2006.B0411


2 Figures and Tables

Slides referencing similar topics